Studies
Canada-wide
- Development and validation of a self-management measure for adults with multiple sclerosis
- Development of a Kid-Centered Preference-based Measure of Disability for Children and Adolescents with Multiple Sclerosis: First Steps - Eliciting Domains of Concern from Children and Parents
British Columbia
Alberta
Nova Scotia
Manitoba
Ontario
- A double-blind placebo controlled study of mixed-amphetamine salts, extended release (Adderall XR) for cognitive impairment in MS
- Validation of the ‘Talking with Your Healthcare Provider’ Program
- Progressive degeneration from onset in pediatric multiple sclerosis: Evaluation of clinical and health-related quality of life, early loss of brain integrity and accelerated immunological senescence
- Investigating blood brain barrier abnormalities during relapses in person with MS
- Attention/Working Memory Rehabilitation in Multiple Sclerosis: A pilot project using Cogmed Working Memory Training
- MEsenchymal Stem cell therapy for CAnadian MS patients - MESCAMS
- Cognitive Impairment Experienced During Multiple Sclerosis Relapses
- Cannabis Use in Multiple Sclerosis: A Cognitive and Neuroimaging Study
- The role of muscle strength and voluntary activation on symptomatic fatigue in multiple sclerosis.
Saskatchewan